Stay informed with the latest litigation news. Explore now
Pharmaceutical Composition Comprising Brivaracetam And Lacosamide With Synergistic Anticonvulsant Effect - EP2992891B1
EP2992891
- Application Number
- EP15156237A
- Filing Date
- Jun 15, 2007
- Status
- Granted And Under Opposition
- Jul 3, 2020
- Grant Date
- Aug 5, 2020
- External Links
- Slate, Register, Google Patents
- Similar Patents facing opposition
Bibliography
The patent EP2992891B1 was granted to UCB Pharma on Aug 5, 2020 following the initial filing on Jun 15, 2007 under the application number EP15156237A . The current legal status of the patent is Granted And Under Opposition.
Patent Summary (AI Generated) New
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.
Date
Description
Get instant alerts for new documents